University of Basra faculty member publishes an article in the Journal of Pharmaceutics in Scopus and Clarvate
Dr. Ammar Yasser Jassim, an instructor at the University of Basra's Marine Science Center, has published a scientific article in collaboration with other researchers titled
(Recent advances in targeting
cancer stem cells by using nanomaterials)
in the International Journal of Pharmaceutics published by Elsevier.
The journal, which has a ScopusQ1 impact factor of 5.3 and a Clarvite rating, publishes articles and research on pharmaceutical nanotechnology and personalized medicine.
The article addresses a new and exciting area at the intersection of materials science and biomedicine, talking about the biology of cancer stem cells and new ways of creating nanoparticles (NPs) that can specifically deliver cancer drugs to these cancer stem cells, and how to create different types of NPs. microparticles including synthetic and natural polymer molecules, lipid molecules, inorganic particles, protein molecules, antibody molecules, embedded drugs, and small bubbles called nanobubbles, all of which are capable of targeting cancer stem cells.
This paper describes recent progress and views on the use of nanotechnology in stem cell research and therapy, and how nanoparticles can help track and control stem cells and improve stem cell retention.
https://www.sciencedirect.com/science/article/abs/pii/S0378517325002170
Department of Media and Communication